The rising global elderly population is a critical factor contributing to the growth of the Atherectomy Devices Market. With age, the prevalence of cardiovascular diseases such as Peripheral Artery Disease (PAD) and coronary blockages increases, creating greater demand for advanced treatment solutions.

Older patients often present with more complex and calcified lesions, which are difficult to treat with conventional angioplasty alone. Atherectomy devices provide a valuable solution in such cases by physically removing plaque and restoring blood flow more effectively. This makes them especially relevant in an aging society.

In developed regions such as North America and Europe, where elderly populations are rapidly increasing, healthcare systems are investing heavily in cardiovascular care. Hospitals are adopting advanced atherectomy devices to handle the growing number of procedures. Similarly, in emerging economies, aging demographics are putting pressure on healthcare infrastructure to adopt modern technologies.

However, the elderly population also brings challenges. Older patients are often at higher risk of complications during surgery, making it

essential for atherectomy devices to be safe, minimally invasive, and efficient. Manufacturers are responding by developing devices with enhanced safety features and more precise plaque removal capabilities.

The Atherectomy Devices Market is therefore closely tied to demographic trends. As life expectancy rises globally, the demand for atherectomy procedures will continue to grow, ensuring long-term market expansion.

For group discussions, participants may explore whether healthcare systems are adequately prepared to meet the cardiovascular needs of aging populations and how device innovation can address the unique risks associated with elderly patients.